Distinct regulation of intrinsic apoptosis in benign and malignant thyroid tumours

C Weidinger1, S Karger, K Krause

  • 1Department of Internal Medicine, Division of Endocrinology and Diabetes, University of Leipzig, Leipzig, Germany.

Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|May 7, 2010
PubMed

Insights

Thyroid cancer involves apoptosis control issues. This study found key apoptosis pathway genes, Bad and Caspase3, are deregulated in thyroid tumors, impacting cancer development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Cell Death Research

Background:

  • Apoptosis control is crucial in thyroid carcinogenesis.
  • Regulation of the intrinsic apoptosis pathway in thyroid tissue is poorly understood.

Purpose of the Study:

  • Investigate mRNA expression of apoptosis-related genes in thyroid tumors.
  • Assess the activation status of Caspase3 in thyroid malignancies.
  • Identify transcriptional and post-transcriptional changes in apoptosis pathways during thyroid cancer development.

Main Methods:

  • Real-time PCR to quantify mRNA levels of Caspase3, Caspase3 s, xIAP, Bad, and beta-actin in 79 thyroid tumors.
  • Immunohistochemistry to evaluate Caspase3 activation status.

Main Results:

  • Significant downregulation of pro-apoptotic Bad mRNA in malignant thyroid tumors.
  • Upregulation of anti-apoptotic Caspase3 s splice variant in follicular and anaplastic thyroid cancers.
  • Papillary thyroid tumors showed increased Caspase3 mRNA levels.
  • Impaired Caspase3 activation in thyroid malignancies, with cytoplasmic accumulation of activated Caspase3.

Conclusions:

  • First evidence of intrinsic apoptosis pathway deregulation at transcriptional and post-transcriptional levels in thyroid cancer.
  • Altered expression of Bad and Caspase3 variants suggests their role in thyroid carcinogenesis.
  • Understanding apoptosis deregulation may offer diagnostic and therapeutic advantages for thyroid cancer management.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The iodine is then...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...